Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award update |
| Buyer: | UNIVERSITY OF NOTTINGHAM (THE) |
| Main Category: | Services |
| Procurement Method: | Single tender action (below threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £76,535.54 |
| Release Date: | 27 January 2023 |
| Application Deadline: | 4 May 2022 |
| Contract Start Date: | 4 May 2022 |
All 2 notices for this procurement, oldest first.
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £76,535.54 |
| Award decision date: | 4 May 2022 |
| Award status: | Active |
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.
Published contracts in the last 12 months
5
total contracts
£543k
total value
£135,625
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
4 May 2022
Closed
Estimated Value
£76,535.54
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 5 May 2022 |
| Contract Duration: | 0 months |
| Procurement ID (OCID): | ocds-b5fd17-74cf7efb-12b0-4713-adbc-9ac8b71113ed |
| Notice Reference: | b7fe11c2-b9bc-4f06-8d38-f5d56d677deb-609355 |